FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3129871103> ?p ?o ?g. }

• W3129871103 endingPage "525" @default.
• W3129871103 startingPage "515" @default.
• W3129871103 abstract "Hyperinflammation distinguishes COVID-19 patients who develop a slight disease or none, from those progressing to severe and critical conditions. CIGB-258 is a therapeutic option for the latter group of patients. This drug is an altered peptide ligand (APL) derived from the cellular stress protein 60 (HSP60). In preclinical models, this peptide developed anti-inflammatory effects and increased regulatory T cell (Treg) activity. Results from a phase I clinical trial with rheumatoid arthritis (RA) patients indicated that CIGB-258 was safe and reduced inflammation. The aim of this study was to examine specific biomarkers associated with hyperinflammation, some cytokines linked to the cytokine storm granzyme B and perforin in a cohort of COVID-19 patients treated with this peptide. All critically ill patients were under invasive mechanical ventilation and received the intravenous administration of 1 or 2 mg of CIGB-258 every 12 h. Seriously ill patients were treated with oxygen therapy receiving 1 mg of CIGB-258 every 12 h and all patients recovered from their severe condition. Biomarker levels associated with hyperinflammation, such as interleukin (IL)-6, IL-10, tumor necrosis factor (TNF-α), granzyme B, and perforin, significantly decreased during treatment. Furthermore, we studied the ability of CIGB-258 to induce Tregs in COVID-19 patients and found that Tregs were induced in all patients studied. Altogether, these results support the therapeutic potential of CIGB-258 for diseases associated with hyperinflammation. Clinical trial registry: RPCEC00000313" @default.
• W3129871103 created "2021-03-01" @default.
• W3129871103 creator A5008998982 @default.
• W3129871103 creator A5028273333 @default.
• W3129871103 creator A5050898488 @default.
• W3129871103 creator A5051993908 @default.
• W3129871103 creator A5059479691 @default.
• W3129871103 creator A5074466541 @default.
• W3129871103 creator A5081912854 @default.
• W3129871103 creator A5085002838 @default.
• W3129871103 creator A5088068830 @default.
• W3129871103 date "2021-02-24" @default.
• W3129871103 modified "2023-10-18" @default.
• W3129871103 title "CIGB-258, a peptide derived from human heat-shock protein 60, decreases hyperinflammation in COVID-19 patients" @default.
• W3129871103 cites W1803784511 @default.
• W3129871103 cites W1981066923 @default.
• W3129871103 cites W1993965822 @default.
• W3129871103 cites W2016029872 @default.
• W3129871103 cites W2017739131 @default.
• W3129871103 cites W2044644799 @default.
• W3129871103 cites W2078835794 @default.
• W3129871103 cites W2099106363 @default.
• W3129871103 cites W2118451050 @default.
• W3129871103 cites W2143660712 @default.
• W3129871103 cites W2158622713 @default.
• W3129871103 cites W2304469553 @default.
• W3129871103 cites W2346657941 @default.
• W3129871103 cites W2409002862 @default.
• W3129871103 cites W2589232255 @default.
• W3129871103 cites W2596384754 @default.
• W3129871103 cites W2610356532 @default.
• W3129871103 cites W2788334812 @default.
• W3129871103 cites W2808305854 @default.
• W3129871103 cites W2889812219 @default.
• W3129871103 cites W2899558899 @default.
• W3129871103 cites W2993844391 @default.
• W3129871103 cites W3001118548 @default.
• W3129871103 cites W3007829007 @default.
• W3129871103 cites W3007940623 @default.
• W3129871103 cites W3009314935 @default.
• W3129871103 cites W3009859788 @default.
• W3129871103 cites W3009885589 @default.
• W3129871103 cites W3011508332 @default.
• W3129871103 cites W3011610993 @default.
• W3129871103 cites W3011812996 @default.
• W3129871103 cites W3012421327 @default.
• W3129871103 cites W3013243519 @default.
• W3129871103 cites W3014003872 @default.
• W3129871103 cites W3014462179 @default.
• W3129871103 cites W3015283396 @default.
• W3129871103 cites W3015321334 @default.
• W3129871103 cites W3016987930 @default.
• W3129871103 cites W3018868982 @default.
• W3129871103 cites W3019031660 @default.
• W3129871103 cites W3023991776 @default.
• W3129871103 cites W3024643080 @default.
• W3129871103 cites W3025063365 @default.
• W3129871103 cites W3025502129 @default.
• W3129871103 cites W3030325615 @default.
• W3129871103 cites W3039206739 @default.
• W3129871103 cites W3040531409 @default.
• W3129871103 cites W3047415564 @default.
• W3129871103 cites W4292528167 @default.
• W3129871103 doi "https://doi.org/10.1007/s12192-021-01197-2" @default.
• W3129871103 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7904296" @default.
• W3129871103 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33629254" @default.
• W3129871103 hasPublicationYear "2021" @default.
• W3129871103 type Work @default.
• W3129871103 sameAs 3129871103 @default.
• W3129871103 citedByCount "13" @default.
• W3129871103 countsByYear W31298711032021 @default.
• W3129871103 countsByYear W31298711032022 @default.
• W3129871103 countsByYear W31298711032023 @default.
• W3129871103 crossrefType "journal-article" @default.
• W3129871103 hasAuthorship W3129871103A5008998982 @default.
• W3129871103 hasAuthorship W3129871103A5028273333 @default.
• W3129871103 hasAuthorship W3129871103A5050898488 @default.
• W3129871103 hasAuthorship W3129871103A5051993908 @default.
• W3129871103 hasAuthorship W3129871103A5059479691 @default.
• W3129871103 hasAuthorship W3129871103A5074466541 @default.
• W3129871103 hasAuthorship W3129871103A5081912854 @default.
• W3129871103 hasAuthorship W3129871103A5085002838 @default.
• W3129871103 hasAuthorship W3129871103A5088068830 @default.
• W3129871103 hasBestOaLocation W31298711031 @default.
• W3129871103 hasConcept C126322002 @default.
• W3129871103 hasConcept C164027704 @default.
• W3129871103 hasConcept C167672396 @default.
• W3129871103 hasConcept C17991360 @default.
• W3129871103 hasConcept C183193105 @default.
• W3129871103 hasConcept C203014093 @default.
• W3129871103 hasConcept C2776062744 @default.
• W3129871103 hasConcept C2776914184 @default.
• W3129871103 hasConcept C71924100 @default.
• W3129871103 hasConcept C8891405 @default.
• W3129871103 hasConceptScore W3129871103C126322002 @default.
• W3129871103 hasConceptScore W3129871103C164027704 @default.
• W3129871103 hasConceptScore W3129871103C167672396 @default.
• W3129871103 hasConceptScore W3129871103C17991360 @default.

• next